Outwitting the Hypoxic Fortress: Self-Assembled Glucose-Powered Mitochondria-Targeting Ru Nanoassemblies for Triad Chemo-Sonodynamic Immunotherapy
Journal of Medicinal Chemistry · 23.04.2026 · 69 (8) · 9743-9756
DOI: 10.1021/acs.jmedchem.6c00767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 14.04.2026. Verfasst von Peng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, P. R. China. Hauptthemen laut MEDLINE: Mitochondria, Glucose, Immunotherapy, Ruthenium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Conventional sonodynamic therapy (SDT) is limited by the immunosuppressive tumor microenvironment (TME), characterized by hypoxia and potent antioxidant defenses. To address these challenges, we developed RGH@TK-FA, a nanoplatform codelivering a mitochondria-targeting ruthenium sonosensitizer (RuSS), glucose oxidase (GOx), and hemoglobin (Hb), encapsulated within a PEG shell modified with folate and ROS-responsive linkers. Under ultrasound, RuSS generates ROS via type I and II mechanisms while depleting cellular reductants. The resulting ROS trigger cargo release, initiating a self-amplifying cascade: GOx consumes glucose and oxygen to produce H2O2 and acidify the TME, while Hb supplies O2 and acts as a Fenton-like catalyst for chemodynamic therapy. ROS also promote iron release from Hb, establishing a self-sustaining feedback loop that intensifies oxidative stress. This ROS storm disrupts redox homeostasis and induces immunogenic cell death via ferroptosis, reprogramming the immunosuppressive TME. This work overcomes SDT limitations through a self-reinforcing multimodal therapeutic cycle for precision cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry School of Chemistry, Sun Yat-Sen University, Guangzhou 510006, P. R. China.
- Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Guangzhou 510006, P. R. China.
- State Key Laboratory of Anti-Infective Drug Discovery and Development School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China.
ORCID-Profile: Qing-Hua Shen, Cai-Ping Tan
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Wang, P., Yu, L. B., Shen, Q. H., Jiang, X. J., Li, Z. Y., Han, Y. Y., & Tan, C. P. (2026). Outwitting the Hypoxic Fortress: Self-Assembled Glucose-Powered Mitochondria-Targeting Ru Nanoassemblies for Triad Chemo-Sonodynamic Immunotherapy. Journal of Medicinal Chemistry, 69(8), 9743-9756. https://doi.org/10.1021/acs.jmedchem.6c00767
Vancouver
Wang P, Yu LB, Shen QH, Jiang XJ, Li ZY, Han YY, et al. Outwitting the Hypoxic Fortress: Self-Assembled Glucose-Powered Mitochondria-Targeting Ru Nanoassemblies for Triad Chemo-Sonodynamic Immunotherapy. Journal of Medicinal Chemistry. 2026;69(8):9743-9756. doi:10.1021/acs.jmedchem.6c00767
BibTeX
@article{Wang2026,
author = {Wang, Peng and Yu, Long-Bo and Shen, Qing-Hua and Jiang, Xiang-Jie and Li, Zhi-Yuan and Han, Ying-Ying and Tan, Cai-Ping},
title = {Outwitting the Hypoxic Fortress: Self-Assembled Glucose-Powered Mitochondria-Targeting Ru Nanoassemblies for Triad Chemo-Sonodynamic Immunotherapy},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {8},
pages = {9743--9756},
doi = {10.1021/acs.jmedchem.6c00767}
}
EUVIMED